🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Immunity

Impact of Smoking on Immune Responses in Peri-implant Health and Disease NCT07750171n/a1 site📍 Ankara Gazi University Walnuts as an Infant Solid Food for Health NCT07081698NA1 site📍 Fort Collins Colorado State University · Tests: Infant walnut intake Using Urine to Study Antibodies & Functional Cell-Mediated Immunity in the Context of Chlamydia Trachomatis NCT07596316n/a1 site📍 Antwerp Universiteit Antwerpen · Tests: Sampling Immunity Markers in Intensive Care Patients and Ventilator-associated Pneumonia NCT06607055n/a1 site📍 Aix-en-Provence Centre Hospitalier Intercommunal Aix-Pertuis · Tests: Blood collection The Safety, Efficacy, and Immune Response of Multimodal Thermal Therapy in the Treatment of Malignant Liver Tumors NCT07159048NA1 site📍 Shanghai Fudan University · Tests: Multimodal Tumor Thermal Therapy System, Radiofrequency Ablation System or Microwave Ablation System Study of Antitumor Immune Response After cCRT and IO Treatment in Non-resectable III Stage NSCLC Patients NCT06634199n/a22 sites📍 Ferrol📍 Alicante📍 Badalona Fundación GECP · Tests: Durvalumab Prospective Immuno-Radiomic Profiling in Nasopharyngeal Carcinoma Treated With Proton or Photon Chemoradiotherapy NCT07232680n/a1 site📍 Taoyuan City Cheng-En Hsieh · Tests: Proton chemoradiotherapy, Photon chemoradiotherapy RSV Vaccination in Immunocompromised Patients. NCT06597916Phase 21 site📍 Vienna Medical University of Vienna · Tests: Arexvy powder and suspension for injection Immunogenicity and Safety of Respiratory Syncytial Virus Vaccine in Lung Transplant Recipients NCT07895394Phase 41 site📍 Seoul Seoul National University Hospital · Tests: RSVPreF3 vaccination Characterisation of Dengue Vaccine-induced Specific Immunity in Vaccinees With and Without Prior Exposure to Flavivirus Infections or Vaccination NCT06776692n/a1 site📍 Negrar IRCCS Sacro Cuore Don Calabria di Negrar · Tests: Qdenga Potential of Moderate Whole Body Hyperthermia to Enhance Response NCT05821166Phase 21 site📍 Berlin Charite University, Berlin, Germany · Tests: moderate Whole Body Hyperthermia (mWBH) Surviving Pneumonia NCT03795662n/a1 site📍 Hillerød Nordsjaellands Hospital · Tests: No intervention Early Severe Illness TrAnslational BioLogy InformaticS in Humans NCT05591924n/a1 site📍 London London Health Sciences Centre Research Institute OR Lawson … · Tests: Phelebotomy, Broncheoalveolar Lavage, Tracheal Aspirate, Rectal Swab The Use of Cytomegalovirus Cell Mediated Immunity to Optimize the Duration of Letermovir Prophylaxis in Hematopoietic Cell Transplant Recipients NCT06639854NA1 site📍 Houston M.D. Anderson Cancer Center · Tests: Hematopoietic Cell Transplant, Letermovir Impaired Type I IFN Immunity Due to Autoantibodies or a Genetic Defect: a Prospective National Cohort NCT06762002n/a9 sites📍 Lille📍 Lyon📍 Montpellier Institut National de la Santé Et de la Recherche Médicale, … · Tests: blood sample A Multi-site Study to Evaluate the Persistence of Protective Immunity to Routine Childhood Vaccinations in Participants With B-ALL/Ly Who Have Received Blinatumomab NCT07422337n/a2 sites📍 Little Rock📍 Springdale Arkansas Children's Hospital Research Institute Mucosal Associated Invariant T Cell During Viral Pneumonia and Acute Respiratory Distress Syndrome NCT06720818n/a1 site📍 Tours University Hospital, Tours Acute Infection in Mitochondrial Disease: Metabolism, Infection and Immunity NCT04419870n/a1 site📍 Bethesda National Human Genome Research Institute (NHGRI) A Study on the Safety and Immune Response of a Urinary Tract Infection (UTI) Vaccine in Adults 18-64 Years of Age and Clinical Efficacy in Females 18-64 Years of Age NCT06702449Phase 1, Phase 28 sites📍 Lenexa📍 Secaucus📍 Rochester GlaxoSmithKline · Tests: Candidate UTI vaccine low dose formulation 1, Candidate UTI vaccine low dose formulation 2, Candidate UTI vaccine mediu… The Effect of 0.1% Topical Ciclosporin A for 12-weeks on the Eye Surface Immune Cells in Dry Eyes NCT06898853NA1 site📍 Sydney The University of New South Wales · Tests: 0.1% Ciclosporin A eye drops, Mineral oils eye drops Safety and Modulation of Adaptive Immunity by Iscador® Qu Viscum Album Extract in Patients With Advanced, Recurrent or Metastatic Cancers Treated With Immune Checkpoint Inhibitors NCT06408688Phase 44 sites📍 Baden📍 Basel📍 Liestal University Hospital, Basel, Switzerland · Tests: Immune checkpoint inhibitors plus Iscador® Qu., Immune Checkpoint Inhibitors The Role of Preoperative Immunonutrition on Morbidity and Immune Response After Cystectomy (INCyst Trial) NCT05726786Phase 34 sites📍 Lausanne📍 Bern📍 Geneva Centre Hospitalier Universitaire Vaudois · Tests: Immunonutrition The Role of IL-23 in Chronic Inflammatory Disease: Exploring the Cellular and Molecular Targets of IL-23 Signaling in Peripheral and Axial Spondyloarthritis NCT05290363NA4 sites📍 Créteil📍 Paris📍 Paris Institut Pasteur · Tests: Blood sampling, synovial aspiration A Study to Evaluate the Immune Response and Safety of a Vaccine Against Influenza in Adults 18-64 Years of Age NCT07851246Phase 312 sites📍 Glendale📍 Tucson📍 San Diego GlaxoSmithKline · Tests: mRNA Seasonal Flu vaccine, Comparator 1, Comparator 2 Respiratory Virome Diversity and Baseline Immunity in Healthy Individuals in Shanghai NCT06641856n/a1 site📍 Shanghai Ruijin Hospital · Tests: Sample Collection Restoration of Immunity to Vaccine Preventable Diseases After CART-T Cell Therapy NCT06333275n/a1 site📍 Bern Insel Gruppe AG, University Hospital Bern · Tests: Vaccines against: Diphtheria, tetanus, pertussis, polio, haemophilus influenza type b, varicella and measles Mucosal and Systemic Immunity Correlates of Protection Against Influenza in Young Children, Aged 2-5 Years (MUSIC-Flu) NCT07861854n/a1 site📍 Jouberton National Institute for Communicable Diseases, South Africa Second Prospective Cohort of Patients Entering the Multidisciplinary Care Pathway for Post-Covid Syndromes - SyPoCo2 Cohort NCT07356570n/a2 sites📍 Pierre-Bénite📍 Saint-Genis-Laval Hospices Civils de Lyon · Tests: Blood sample collection HN-BIO 02: A Phase II Randomized Study of the Effects of Delayed Elective Radiotherapy on Head and Neck MRI and Immune Response Biomarkers NCT06487403NA1 site📍 Toronto University Health Network, Toronto · Tests: Standard of care external beam radiotherapy (single integrated boost), Standard of care external beam radiotherapy (two… Gut Microbiome and Treatment for Gynecological Cancer Patients Receiving Immunotherapy NCT04957511n/a1 site📍 Orlando Viome
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy